An Opportunity for Hospice Referral in Acute Myeloid Leukemia: Prognostic Significance of Hospitalization Status at Time of Second Cycle of Hypomethylating Agents for Patients Ineligible for Intensive Induction Chemotherapy

Douglas Tremblay; Rafael Madero-Marroquin; Guido Lancman; Alexander Coltoff; Jonathan Feld; Jessica Caro; Emily Sherlock; Alla Keyzner; Shyamala Navada; Lewis R. Silverman; Erin Moshier; Nicole Zubizarreta; John Mascarenhas

doi:10.1089/jpm.2020.0355

An Opportunity for Hospice Referral in Acute Myeloid Leukemia: Prognostic Significance of Hospitalization Status at Time of Second Cycle of Hypomethylating Agents for Patients Ineligible for Intensive Induction Chemotherapy

Douglas Tremblay, Rafael Madero-Marroquin, Guido Lancman, Alexander Coltoff, Jonathan Feld, Jessica Caro, Emily Sherlock, Alla Keyzner, Shyamala Navada, Lewis R. Silverman, Erin Moshier, Nicole Zubizarreta, John Mascarenhas

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1424-1425
Number of pages	2
Journal	Journal of Palliative Medicine
Volume	23
Issue number	11
DOIs	https://doi.org/10.1089/jpm.2020.0355
State	Published - Nov 2020

Access to Document

10.1089/jpm.2020.0355

Cite this

Tremblay, D., Madero-Marroquin, R., Lancman, G., Coltoff, A., Feld, J., Caro, J., Sherlock, E., Keyzner, A., Navada, S., Silverman, L. R., Moshier, E., Zubizarreta, N., & Mascarenhas, J. (2020). An Opportunity for Hospice Referral in Acute Myeloid Leukemia: Prognostic Significance of Hospitalization Status at Time of Second Cycle of Hypomethylating Agents for Patients Ineligible for Intensive Induction Chemotherapy. Journal of Palliative Medicine, 23(11), 1424-1425. https://doi.org/10.1089/jpm.2020.0355

Tremblay, Douglas ; Madero-Marroquin, Rafael ; Lancman, Guido et al. / An Opportunity for Hospice Referral in Acute Myeloid Leukemia : Prognostic Significance of Hospitalization Status at Time of Second Cycle of Hypomethylating Agents for Patients Ineligible for Intensive Induction Chemotherapy. In: Journal of Palliative Medicine. 2020 ; Vol. 23, No. 11. pp. 1424-1425.

@article{42077578ffb64c0d9ec2e749d163689c,

title = "An Opportunity for Hospice Referral in Acute Myeloid Leukemia: Prognostic Significance of Hospitalization Status at Time of Second Cycle of Hypomethylating Agents for Patients Ineligible for Intensive Induction Chemotherapy",

author = "Douglas Tremblay and Rafael Madero-Marroquin and Guido Lancman and Alexander Coltoff and Jonathan Feld and Jessica Caro and Emily Sherlock and Alla Keyzner and Shyamala Navada and Silverman, {Lewis R.} and Erin Moshier and Nicole Zubizarreta and John Mascarenhas",

note = "Funding Information: grants from Janssen, grants from Merck, grants from Roche, grants from Promedior, grants and nonfinancial support from Celgene, and grants from Pharmaessentia. The rest of the authors declare that they have no conflict of interest. This study was funded internally without support from the afore-mentioned companies. The authors have full control of all primary data and have agreed to allow the journal to review their data if requested. Funding Information: The authors have the following conflicts of interest to report: S.N. receives research funding from Onconova Therapeutics. J.M. reports grants and nonfinancial support from Incyte, grants and nonfinancial support from CTI Biopharma,",

year = "2020",

month = nov,

doi = "10.1089/jpm.2020.0355",

language = "English",

volume = "23",

pages = "1424--1425",

journal = "Journal of Palliative Medicine",

issn = "1096-6218",

publisher = "Mary Ann Liebert Inc.",

number = "11",

}

Tremblay, D, Madero-Marroquin, R, Lancman, G, Coltoff, A, Feld, J, Caro, J, Sherlock, E, Keyzner, A, Navada, S, Silverman, LR, Moshier, E, Zubizarreta, N & Mascarenhas, J 2020, 'An Opportunity for Hospice Referral in Acute Myeloid Leukemia: Prognostic Significance of Hospitalization Status at Time of Second Cycle of Hypomethylating Agents for Patients Ineligible for Intensive Induction Chemotherapy', Journal of Palliative Medicine, vol. 23, no. 11, pp. 1424-1425. https://doi.org/10.1089/jpm.2020.0355

An Opportunity for Hospice Referral in Acute Myeloid Leukemia: Prognostic Significance of Hospitalization Status at Time of Second Cycle of Hypomethylating Agents for Patients Ineligible for Intensive Induction Chemotherapy. / Tremblay, Douglas; Madero-Marroquin, Rafael; Lancman, Guido et al.
In: Journal of Palliative Medicine, Vol. 23, No. 11, 11.2020, p. 1424-1425.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - An Opportunity for Hospice Referral in Acute Myeloid Leukemia

T2 - Prognostic Significance of Hospitalization Status at Time of Second Cycle of Hypomethylating Agents for Patients Ineligible for Intensive Induction Chemotherapy

AU - Tremblay, Douglas

AU - Madero-Marroquin, Rafael

AU - Lancman, Guido

AU - Coltoff, Alexander

AU - Feld, Jonathan

AU - Caro, Jessica

AU - Sherlock, Emily

AU - Keyzner, Alla

AU - Navada, Shyamala

AU - Silverman, Lewis R.

AU - Moshier, Erin

AU - Zubizarreta, Nicole

AU - Mascarenhas, John

N1 - Funding Information: grants from Janssen, grants from Merck, grants from Roche, grants from Promedior, grants and nonfinancial support from Celgene, and grants from Pharmaessentia. The rest of the authors declare that they have no conflict of interest. This study was funded internally without support from the afore-mentioned companies. The authors have full control of all primary data and have agreed to allow the journal to review their data if requested. Funding Information: The authors have the following conflicts of interest to report: S.N. receives research funding from Onconova Therapeutics. J.M. reports grants and nonfinancial support from Incyte, grants and nonfinancial support from CTI Biopharma,

PY - 2020/11

Y1 - 2020/11

UR - http://www.scopus.com/inward/record.url?scp=85096133430&partnerID=8YFLogxK

U2 - 10.1089/jpm.2020.0355

DO - 10.1089/jpm.2020.0355

M3 - Letter

C2 - 33174777

AN - SCOPUS:85096133430

SN - 1096-6218

VL - 23

SP - 1424

EP - 1425

JO - Journal of Palliative Medicine

JF - Journal of Palliative Medicine

IS - 11

ER -

Tremblay D, Madero-Marroquin R, Lancman G, Coltoff A, Feld J, Caro J et al. An Opportunity for Hospice Referral in Acute Myeloid Leukemia: Prognostic Significance of Hospitalization Status at Time of Second Cycle of Hypomethylating Agents for Patients Ineligible for Intensive Induction Chemotherapy. Journal of Palliative Medicine. 2020 Nov;23(11):1424-1425. doi: 10.1089/jpm.2020.0355